These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10974772)

  • 1. [Seroprevalence of parvovirus B19 in our area and its distribution by ages and sexes].
    Güerri ML; Prior C; Merino R; Zapico R
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):243-4. PubMed ID: 10974772
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies against human parvovirus B19 in the Madrid community].
    de Ory F; Pachón I; Ramírez R; Echevarría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):364-5. PubMed ID: 10535193
    [No Abstract]   [Full Text] [Related]  

  • 3. Rising incidence of parvovirus B19 infection.
    Commun Dis Rep CDR Wkly; 1998 Mar; 8(11):93, 96. PubMed ID: 9563206
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia.
    Ooi SL; Hooi PS; Chua BH; Lam SK; Chua KB
    Med J Malaysia; 2002 Mar; 57(1):97-103. PubMed ID: 14569725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.
    Miron D; Horovitz Y; Luder A; Ohnona FS; Schlesinger Y
    Isr Med Assoc J; 2010 May; 12(5):277-9. PubMed ID: 20929079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroprevalence study of parvovirus B19 in Poland].
    Siennicka J; Stefanoff P; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2006; 60(3):571-80. PubMed ID: 17249182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroprevalence of human parvovirus B19 in ambulatory population of Cantabria, northern Spain].
    Ruiz de Alegría Puig C; Balbás García de Bustos R; Herrera González MC; Martínez-Bernal MA
    An Pediatr (Barc); 2009 Nov; 71(5):475-6. PubMed ID: 19783492
    [No Abstract]   [Full Text] [Related]  

  • 8. Parvovirus B-19 infection during pregnancy.
    Al-Khan A; Caligiuri A; Apuzzio J
    Infect Dis Obstet Gynecol; 2003; 11(3):175-9. PubMed ID: 15022880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
    Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
    BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of parvovirus B19.
    Commun Dis Rep CDR Wkly; 1997 Jun; 7(26):229. PubMed ID: 9219425
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study.
    LaMonte AC; Paul ME; Read JS; Frederick MM; Erdman DD; Han LL; Anderson LJ;
    J Infect Dis; 2004 Mar; 189(5):847-51. PubMed ID: 14976602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
    Ziyaeyan M; Rasouli M; Alborzi A
    Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parvovirus B19 infection in pregnancy: a cause of non-immune hydrops fetalis].
    Reintjes R; Bosman A; Buitenwerf J
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):542. PubMed ID: 10321269
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical inquiry: What should you tell pregnant women about exposure to parvovirus?
    Snyder M; Wallace R
    J Fam Pract; 2011 Dec; 60(12):765-6. PubMed ID: 22163362
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of perinatal transmission of rubella and parvovirus B19 in Jordanian pregnant women.
    Bdour S
    Vaccine; 2006 Apr; 24(16):3309-12. PubMed ID: 16460842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrothorax as a sole manifestation of congenital parvovirus B19 infection.
    Sarafidis K; Drossou-Agakidou V; Evdoridou I; Petridou S; Hatzisevastou-Loukidou H; Dadamojas C; Roilides E
    Am J Perinatol; 2008 Oct; 25(9):551-4. PubMed ID: 18773380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of factor analysis in the study of risk factors on human parvovirus B19 infection during pregnancy].
    Huang YM; Li ZQ; Qiao FY; Liu HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):859-62. PubMed ID: 15631741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
    van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: a report from a single Spanish institution.
    Canales MA; Pinilla J; Mateos P; Martínez Zapico R; Alvarez T; Jiménez VM; Quintana M; Villar A; Hernández Navarro F; Magallón M
    Vox Sang; 1998; 74(4):260-1. PubMed ID: 9691409
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpes virus 7.
    Chow SS; Craig ME; Jacques CF; Hall B; Catteau J; Munro SC; Scott GM; Camaris C; McIver CJ; Rawlinson WD
    J Med Virol; 2006 Jun; 78(6):747-56. PubMed ID: 16628574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.